Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat

European Journal of Pharmacology

Volumn 558, Issue 1-3, 2007, Pages 60-67

  Obara, Ilona ^a   Makuch, Wioletta ^a   Spetea, Mariana ^b   Schütz, Johannes ^b   Schmidhammer, Helmut ^b   Przewlocki, Ryszard ^a   Przewlocka, Barbara ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

^b UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

14 O methyloxymorphone; Inflammatory pain; Morphine; Naloxone methiodide; Neuropathic pain

Indexed keywords

17 METHYLNALOXONE; HS 730; HS 731; HS 937; HS 938; MORPHINE; MORPHINE DERIVATIVE; MU OPIATE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; INFLAMMATION; MALE; NEUROPATHIC PAIN; NONHUMAN; PRIORITY JOURNAL; RAT;

ANALGESICS, OPIOID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; HYPERALGESIA; INFLAMMATION; MALE; MORPHINE; NALOXONE; NEURALGIA; OXYMORPHONE; PAIN; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 33847278343     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.11.037     Document Type: Article

References (36)

1. Amann R., Lanz I., and Schuligoi R. Effects of morphine on oedema and tissue concentration of nerve growth factor in experimental inflammation of the rat paw. Pharmacology 66 (2002) 169-172
2. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
3. Bileviciute-Ljungar I., Spetea M., Guo Y., Schütz J., Windisch P., and Schmidhamme H. Peripherally mediated antinociception of the μ-opioid receptor agonist 2-[(4,5α-Epoxy-3-hydroxy-14β-methoxy-17-methylmorphinan-6β-yl)amino]acetic Acid (HS-731) after subcutaneous and oral administration in rats with carrageenan-induced hindpaw inflammation. J. Pharmacol. Exp. Ther. 317 (2006) 220-227
4. Cerchietti L.C., Navigante A.H., Korte M.W., Cohen A.M., Quiroga P.N., Villaamil E.C., Bonomi M.R., and Roth B.M. Potential utility of the peripheral analgesic properties of morphine in stomatitis-related pain: a pilot study. Pain 105 (2003) 265-273
5. Clatworthy A.L., Illich P.A., Castro G.A., and Walters E.T. Role of peri-axonal inflammation in the development of thermal hyperalgesia and guarding behavior in a rat model of neuropathic pain. Neurosci. Lett. 184 (1995) 5-8
6. Coderre T.J., Fundytus M.E., McKenna J.E., Dalal S., and Melzack R. The formalin test: a validation of the weighted-scores method of behavioural pain rating. Pain 54 (1993) 43-50
7. Coggeshall R.E., and Carlton S.M. Receptor localization in the mammalian dorsal horn and primary afferent neurons. Brain Res. Brain Res. Rev. 24 (1997) 28-66
8. DeHaven-Hudkins D.L., and Dolle R.E. Peripherally restricted opioid agonists as novel analgesic agents. Curr. Pharm. Des. 10 (2004) 743-757
9. Dionne R.A., Lepinski A.M., Gordon S.M., Jaber L., Brahim J.S., and Hargreaves K.M. Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation. Clin. Pharmacol. Ther. 70 (2001) 66-73
10. Fürst S., Riba P., Friedmann T., Timar J., Al-Khrasani M., Obara I., Makuch W., Spetea M., Schütz J., Przewlocki R., Przewlocka B., and Schmidhammer H. Peripheral versus central antinociceptive actions of 6-amino acid-substituted derivatives of 14-O-methyloxymorphone in acute and inflammatory pain in the rat. J. Pharmacol. Exp. Ther. 12 (2005) 609-618
11. Hassan A.H., Ableitner A., Stein C., and Herz A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55 (1993) 185-195
12. Hong Y., and Abbott F.V. Peripheral opioid modulation of pain and inflammation in the formalin test. Eur. J. Pharmacol. 277 (1995) 21-28
13. Janson W., and Stein C. Peripheral opioid analgesia. Curr. Pharm. Biotechnol. 4 (2003) 270-274
14. Kalso E., Tramer M.R., Carroll D., McQuay H.J., and Moore R.A. Pain relief from intra-articular morphine after knee surgery: a qualitative systematic review. Pain 71 (1997) 127-134
15. Likar, R., Schafer, M., Trampitsch, E., Breschan, C., Sittll, R., Gaggl, A., Stein, C., 2005. Topical application of local anesthetics and opioids after elective tooth extraction. Schmerz 19, 195-8, 200.
16. MacPherson R.D. New directions in pain management. Drugs Today (Barc) 38 (2002) 135-145
17. Mousa S.A., Zhang Q., Sitte N., Ji R., and Stein C. beta-Endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J. Neuroimmunol. 115 (2001) 71-78
18. Obara I., Przewlocki R., and Przewlocka B. Local peripheral effects of mu-opioid receptor agonists in neuropathic pain in rats. Neurosci. Lett. 360 (2004) 85-89
19. Pertovaara A., and Wei H. Peripheral effects of morphine in neuropathic rats: role of sympathetic postganglionic nerve fibers. Eur. J. Pharmacol. 429 (2001) 139-145
20. Platzer M., Likar R., Stein C., Beubler E., and Sittl R. Topical application of morphine gel in inflammatory mucosal and cutaneous lesions. Schmerz 19 (2005) 296-301
21. Przewlocki R., and Przewlocka B. Opioids in chronic pain. Eur. J. Pharmacol. 429 (2001) 79-91
22. Przewlocki R., Hassan A.H., Lason W., Epplen C., Herz A., and Stein C. Gene expression and localization of opioid peptides in immune cells of inflamed tissue: functional role in antinociception. Neuroscience 48 (1992) 491-500
23. Puehler W., Zöllner C., Brack A., Shaqura M.A., Krause H., Schäfer M., and Stein C. Rapid upregulation of mu opioid receptor mRNA in dorsal root ganglia in response to peripheral inflammation depends on neuronal conduction. Neuroscience 129 (2004) 473-479
24. Rashid M.H., Inoue M., Toda K., and Ueda H. Loss of peripheral morphine analgesia contributes to the reduced effectiveness of systemic morphine in neuropathic pain. J. Pharmacol. Exp. Ther. 309 (2004) 380-387
25. Sacerdote P., Bianchi M., and Panerai A.E. Involvement of beta-endorphin in the modulation of paw inflammatory edema in the rat. Regul. Pept. 63 (1996) 79-83
26. Schütz J., Spetea M., Koch M., Aceto M.D., Harris L.S., Coop A., and Schmidhammer H. Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesic. J. Med. Chem. 46 (2003) 4182-4187
27. Spetea M., Friedmann T., Riba P., Schütz J., Wunder G., Langer T., Schmidhammer H., and Fürst S. In vitro opioid activity profiles of 6-amino acid substituted derivatives of 14-O-methyloxymorphone. Eur. J. Pharmacol. 483 (2004) 301-308
28. Stein C. The control of pain in peripheral tissue by opioids. N. Engl. J. Med. 332 (1995) 1685-1690
29. Stein C., Hassan A.H., Przewlocki R., Gramsch C., Peter K., and Herz A. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. Natl. Acad. Sci. U. S. A. 87 (1990) 5935-5939
30. Stein C., Machelska H., Binder W., and Schäfer M. Peripheral opioid analgesia. Curr. Opin. Pharmacol. 1 (2001) 62-65
31. Truong W., Cheng C., Xu Q.G., Li X.Q., and Zochodne D.W. Mu opioid receptors and analgesia at the site of a peripheral nerve injury. Ann. Neurol. 53 (2003) 366-375
32. Wang H., and Wessendorf M.W. Equal proportions of small and large DRG neurons express opioid receptor mRNAs. J. Comp. Neurol. 429 (2001) 590-600
33. Wenk H.N., and Honda C.N. Immunohistochemical localization of delta opioid receptors in peripheral tissues. J. Comp. Neurol. 408 (1999) 567-579
34. Whiteside G.T., Boulet J.M., and Walker K. The role of central and peripheral mu opioid receptors in inflammatory pain and edema: a study using morphine and DiPOA ([8-(3,3-diphenyl-propyl)-4-oxo-1-phenyl-1,3,8-triaza-spiro[4.5]dec-3-yl]-acetic acid). J. Pharmacol. Exp. Ther. 314 (2005) 1234-1240
35. Zhang X., Bao L., Shi T.J., Ju G., Elde R., and Hökfelt T. Down-regulation of mu-opioid receptors in rat and monkey dorsal root ganglion neurons and spinal cord after peripheral axotomy. Neuroscience 82 (1998) 223-240
36. Zöllner C., Shaqura M.A., Bopaiah C.P., Mousa S., Stein C., and Schäfer M. Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol. Pharmacol. 64 (2003) 202-210